Literature DB >> 596947

Prospective analysis of antiribonucleoprotein antibodies in systemic lupus erythematosus.

B Bresnihan, R Grigor, G R Hughes.   

Abstract

A prospective analysis of 50 successive patients with systemic lupus erythematosus, seen over a 4-year period, has been completed. 336 sera were examined for the presence of antibody to ribonucleoprotein using a counterimmunoelectrophoresis assay. Antibody was present in the sera of 16% of patients and was detectable in about the same titre throughout the course of the disease. The presence of the antibody did not appear to identify a subgroup of lupus patients with individual clinical characteristics.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 596947      PMCID: PMC1000162          DOI: 10.1136/ard.36.6.557

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.

Authors:  N Kurata; E M Tan
Journal:  Arthritis Rheum       Date:  1976 May-Jun

2.  Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid.

Authors:  R T Wold; F E Young; E M Tan; R S Farr
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

3.  Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus.

Authors:  M Reichlin; M Mattioli
Journal:  N Engl J Med       Date:  1972-04-27       Impact factor: 91.245

4.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

5.  Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus.

Authors:  J B Winfield; D Koffler; H G Kunkel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Characteristics of patients with serum antibodies to extractable nuclear antigens.

Authors:  J H Leibfarth; R H Persellin
Journal:  Arthritis Rheum       Date:  1976 Sep-Oct

7.  Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy.

Authors:  G C Sharp; W S Irvin; R L LaRoque; C Velez; V Daly; A D Kaiser; H R Holman
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

8.  Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis.

Authors:  B Bresnihan; C Bunn; M L Snaith; G R Hughes
Journal:  Br Med J       Date:  1977-03-05
  8 in total
  6 in total

Review 1.  Systemic lupus erythematosus clinical issues.

Authors:  M B Stevens
Journal:  Springer Semin Immunopathol       Date:  1986

2.  Systemic lupus erythematosus. A prospective analysis.

Authors:  R Grigor; J Edmonds; R Lewkonia; B Bresnihan; G R Hughes
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

3.  Antibodies to distinct polypeptides of RNA polymerase I in sera from patients with rheumatic autoimmune disease.

Authors:  D A Stetler; K M Rose; M E Wenger; C M Berlin; S T Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

4.  Systemic lupus erythematosus in North Indian Asians. A prospective analysis of clinical and immunological features.

Authors:  A N Malaviya; R Misra; S Banerjee; A Kumar; S C Tiwari; U N Bhuyan; K K Malhotra; J S Guleria
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

5.  In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.

Authors:  J V Wells; J Webb; M Van Deventer; B Fry; K M Pollard; J Raftos; W Monk; D S Nelson
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

6.  Analysis of speckled fluorescent antinuclear antibody test antisera using electrofocused nuclear antigens.

Authors:  T B Okarma; J A Krueger; H R Holman
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.